Reuters logo
BRIEF-CSPC Pharmaceutical says unit entered into an agreement on Dec 9
December 14, 2016 / 10:02 AM / 9 months ago

BRIEF-CSPC Pharmaceutical says unit entered into an agreement on Dec 9

Dec 14 (Reuters) - CSPC Pharmaceutical Group Ltd :

* Conjupro agrees to grant right to Citron to perform necessary clinical development and apply for relevant approvals

* On 9 dec, unit Conjupro Biotherapeutics, Inc. entered into an agreement with Citron Pharma Limited

* Citron will make milestone payments to Conjupro of up to an aggregate amount of us$81.5 million subject to product’s application progress

* Pursuant to deal, Conjupro is responsible for development of product and technology in relation to manufacturing of product Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below